Tolerance
pharmacologyA diminished response to a substance after repeated use, requiring larger doses for the same effect — a key driver of escalating use.
Tolerance is the process by which the body and brain adapt to repeated exposure to a substance, progressively blunting its effects. What once produced a strong response at a given dose produces a weaker one — so a person must use more of the substance to reach the same result.
It is not a character flaw or a sign of recklessness; it is a predictable biological response to sustained chemical input. Tolerance can develop across days, weeks, or months, depending on the substance and how frequently it is used.
How it works · its role
Two broad mechanisms drive most tolerance. The first is pharmacodynamic tolerance: the brain responds to persistent stimulation by reducing its own sensitivity — receptors may decrease in number (downregulation), shift away from the cell surface, or become less responsive to activation. The signal gets quieter even when the same amount of drug is present.
The second is pharmacokinetic tolerance: the body becomes more efficient at metabolising the substance, so less of it reaches its target in the first place. Alcohol and many sedatives follow this pathway, as repeated use upregulates the liver enzymes responsible for breaking them down.
For most psychoactive substances, pharmacodynamic changes at the receptor level dominate. A third, narrower mechanism — behavioural tolerance — describes learned compensation, where a person unconsciously adapts their behaviour to mask or manage impairment.
Relevance to substances & effects
Tolerance develops at different rates across substance classes. Opioids can produce meaningful tolerance within days of regular use; the analgesic and euphoric effects diminish well before other effects like constipation do, which is one reason dose escalation carries escalating risk.
Classic psychedelics such as LSD and psilocin produce rapid, pronounced tolerance — near-complete after two or three consecutive days of use — driven by rapid 5-HT₂A receptor downregulation. This is also the basis of cross-tolerance among that class: a person tolerant to one classic psychedelic will respond weakly to others.
Cannabinoids, stimulants, and benzodiazepines each produce their own tolerance curves. Stimulants tend to show tolerance to euphoric effects before cardiovascular effects, while benzodiazepine tolerance to sedation can develop faster than tolerance to physical dependence — a distinction that matters during discontinuation.
Tolerance & dependence
Tolerance is closely related to dependence but is not the same thing. Tolerance means reduced effect; dependence means the body has reorganised around the substance's presence and requires it to function normally.
The two often develop together. As tolerance builds, doses rise; as doses rise and use continues, the adaptations underlying tolerance can tip into physical dependence. Withdrawal — the rebound discomfort that appears when the substance is removed — is essentially those same adaptations expressing themselves in its absence.
Tolerance is also largely reversible. After a period of abstinence, sensitivity typically returns, sometimes fully. This creates a well-documented risk: a person who stops using, loses their tolerance, and then returns to their previous dose may encounter an effect far stronger than anticipated.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.